";s:4:"text";s:3265:"But our intent is to ask governments that they should, for these prices, they should provide it free of charge to all citizens.It is not my intention. I can’t measure that with the cost of, let’s say, $2 billion that we may lose on this thing.It’s a symbolic move that’s helping to build the culture of what every pharmaceutical company should be having. It won 10 FDA approvals over the course of 2019. So I am extremely proud of the value that this industry is bringing to the world. Bourla also oversaw the acquisition of Vivet Therapeutics, Therachon Holding, and Akcea Therapeutics over the course of the year.At the start of the year, Bourla rolled out a new “Purpose Blueprint” designed to support the company’s renewed focus on R&D and “breakthroughs that change patients’ lives.” Bourla targeted five areas where he sought to leverage Pfizer’s strengths: its patients and employees, research and development programs, the company’s go-to-market model, digital technologies, and Pfizer’s position in the global pharmaceutical conversation.Eli Lilly has refocused around new medicines and met many of its compensation targets in 2019, the company said in a proxy filing.But Pfizer won nods for new drugs, too, including Vyndaqel for ATTR cardiomyopathy and a suite of biosimilars, including knockoffs of top Roche cancer meds.Bourla certainly had his work cut out for him, and he came out of the gate making bold promises about Pfizer’s future.It’s so far, so good for Albert Bourla’s first year at the helm. We were discussing that back in March, what that means to human lives, to the economy of the world. So for a potential approval in October, if we are lucky. And I think this is what our investors want to hear, that Pfizer can use their resources and can distinguish itself by bringing a solution to the world that very few can bring. Right now we represent the hope for billions of people, millions of businesses and hundreds of governments to find a solution to this mess.Well, let me be accurate and factual here. But we are proud about it, as we are proud about Lipitor (a medicine that lowers cholesterol and is also now off patent protection), which was much bigger than Viagra and likely prevented the deaths of hundreds of millions of people. Special Reports. And my Ph.D. was in biology—biotechnology of reproduction.